Bioregenx (BRGX) Amortization of Deferred Charges (2024 - 2025)

Bioregenx's (BRGX) quarterly Amortization of Deferred Charges came in at $1976.0 in Q3 2025, down 77.05% year-on-year from $8609.0 in Q3 2024, and up 265.22% quarter-over-quarter from -$1196.0 in Q2 2025.

Bioregenx (BRGX) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends

Bioregenx's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $1976.0 for Q3 2025.

  • On a quarterly basis, Amortization of Deferred Charges fell 77.05% year-over-year to $1976.0 in Q3 2025; TTM through Mar 2026 was $780.0, a 98.05% decrease from a year earlier, with the FY2025 full-year figure at $2295.0, down 95.38% from the prior year.
  • Amortization of Deferred Charges grew to $1976.0 in Q3 2025 per BRGX's latest filing, from -$1196.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $16213.0 in Q4 2024 and bottomed at -$1196.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn
9 Privia Health 3.10 Bn 2.73 Bn -
10 Bioregenx 9.69 Mn 9.65 Mn 348,288.00

Historic Data

Download Data
DateValue
Sep 30, 2025 1,976.00
Sep 30, 2025 1,976.00
Jun 30, 2025 -1,196.00
Jun 30, 2025 -1,196.00
Mar 31, 2025 1,515.00
Mar 31, 2025 1,515.00
Dec 31, 2024 16,213.00
Dec 31, 2024 16,213.00
Sep 30, 2024 8,609.00
Sep 30, 2024 8,609.00
Jun 30, 2024 13,573.00
Jun 30, 2024 13,573.00
Mar 31, 2024 11,228.00
Mar 31, 2024 11,228.00